L. Cervenakova et al., PHENOTYPE-GENOTYPE STUDIES IN KURU - IMPLICATIONS FOR NEW VARIANT CREUTZFELDT-JAKOB-DISEASE, Proceedings of the National Academy of Sciences of the United Statesof America, 95(22), 1998, pp. 13239-13241
The PRNP polymorphic (methionine/valine) codon 129 genotype influences
the phenotypic features of transmissible spongiform encephalopathy. A
ll tested cases of new variant Creutzfeldt-Jakob disease (nvCJD) have
been homozygous for methionine, and it is conjectural whether differen
t genotypes, if they appear, might have distinctive phenotypes and imp
lications for the future ''epidemic curve'' of nvCJD, Genotype-phenoty
pe studies of kuru, the only other orally transmitted transmissible sp
ongiform encephalopathy, might be instructive in predicting the answer
s to these questions. We therefore extracted DNA from blood clots or s
era from 92 kuru patients, and analyzed their codon 129 PRNP genotypes
with respect to the age at onset and duration of illness and, in nine
cases, to detailed clinical and neuropathology data. Homozygosity at
codon 129 (particularly for methionine) was associated with an earlier
age at onset and a shorter duration of illness than was heterozygosit
y, but other clinical characteristics were similar for all genotypes.
In the nine neuropathologically examined cases, the presence of histol
ogically recognizable plaques was limited to cases carrying at least o
ne methionine allele (three homozygotes and one heterozygote). If nvCJ
D behaves like kuru, future cases (with longer incubation periods) may
begin to occur in older individuals with heterozygous codon 129 genot
ypes and signal a maturing evolution of the nvCJD ''epidemic.'' The cl
inical phenotype of such cases should be similar to that of homozygous
cases, but may have less (or at least less readily identified) amyloi
d plaque formation.